MedicaidPrior AuthMedium impact
Ixempra (ixabepilone) (New)
Humana·IN · Oncology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Indiana has established a new prior authorization policy for Ixempra (ixabepilone), an IV chemotherapy drug for metastatic breast cancer. Prior authorization is now required for all Ixempra prescriptions with specific criteria related to disease progression and previous treatment failures.
Action Required
By November 1, 2025: Billing team must implement prior authorization requirements for all Ixempra (ixabepilone) prescriptions for Humana Medicaid Indiana patients. Update system to flag these cases and ensure providers document locally advanced or metastatic breast cancer diagnosis plus resistance/refractory status to required previous treatments (anthracyclines, taxanes, capecitabine). Claims will be denied without proper prior authorization.